NBC News
@NBCNews·11.9M subscribers·98K videos
FDA grants full approval for new Alzheimer’s drug
Posted
July 7, 2023
Views
4,351
Likes
39
Comments
14
Engagement
1.22%
July 7, 2023
4,351
39
14
1.22%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:23Now PlayingThe FDA granted full approval to a new medication that aims to slow down the progression of Alzheimer’s disease. NBC News’ Kate Snow shares more about both the significance of the medication and the controversy.
» Subscribe to NBC News
» Watch more NBC video
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App
Breaking News Alerts
Visit NBCNews.Com
Find NBC News on Facebook
Follow NBC News on Twitter
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters
#NBCNews #Alzheimers #FDA
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
